These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24752478)

  • 1. A floating hydrogel system capable of generating CO2 bubbles to diminish urinary obstruction after intravesical instillation.
    Lin T; Zhang Y; Wu J; Zhao X; Lian H; Wang W; Guo H; Hu Y
    Pharm Res; 2014 Oct; 31(10):2655-63. PubMed ID: 24752478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ floating hydrogel for intravesical delivery of adriamycin without blocking urinary tract.
    Lin T; Wu J; Zhao X; Lian H; Yuan A; Tang X; Zhao S; Guo H; Hu Y
    J Pharm Sci; 2014 Mar; 103(3):927-36. PubMed ID: 24449076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: A Floating Hydrogel System Capable of Generating CO2 Bubbles to Diminish Urinary Obstruction after Intravesical Instillation.
    Chang SS
    J Urol; 2016 Feb; 195(2):525-6. PubMed ID: 26853038
    [No Abstract]   [Full Text] [Related]  

  • 4. Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release.
    Zhu G; Zhang Y; Wang K; Zhao X; Lian H; Wang W; Wang H; Wu J; Hu Y; Guo H
    Drug Deliv; 2016 Oct; 23(8):2820-2826. PubMed ID: 26515239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation.
    Lin T; Zhao X; Zhang Y; Lian H; Zhuang J; Zhang Q; Chen W; Wang W; Liu G; Guo S; Wu J; Hu Y; Guo H
    Materials (Basel); 2016 Dec; 9(12):. PubMed ID: 28774123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.
    Yoon HY; Chang IH; Goo YT; Kim CH; Kang TH; Kim SY; Lee SJ; Song SH; Whang YM; Choi YW
    Int J Nanomedicine; 2019; 14():6249-6268. PubMed ID: 31496684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained intravesical drug delivery using thermosensitive hydrogel.
    Tyagi P; Li Z; Chancellor M; De Groat WC; Yoshimura N; Huang L
    Pharm Res; 2004 May; 21(5):832-7. PubMed ID: 15180342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of a floating poloxamer 407-based hydrogel using the Box-Behnken design: in vitro characterization and in vivo buoyancy evaluation for intravesical instillation.
    Goo YT; Yang HM; Kim CH; Kim MS; Kim HK; Chang IH; Choi YW
    Eur J Pharm Sci; 2021 Aug; 163():105885. PubMed ID: 34022408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postoperative intravesical instillation of THP for superficial bladder tumor: clinical results of prophylactic effects on the recurrence. Fukushima THP Research Group].
    Aikawa K; Irisawa C; Muraki O; Yamaguchi O; Shiraiwa Y; Noguchi M; Koguchi M; Yokoyama J; Ito K; Kumakawa K
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):509-13. PubMed ID: 1558401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group.
    Naito S; Kotoh S; Omoto T; Osada Y; Sagiyama K; Iguchi A; Ariyoshi A; Hiratsuka Y; Kumazawa J
    Cancer Chemother Pharmacol; 1998; 42(5):367-72. PubMed ID: 9771950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
    Ueda T; Naito S; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S31-6. PubMed ID: 1394813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
    Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
    Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized controlled release of bevacizumab and doxorubicin by thermo-sensitive hydrogel for normalization of tumor vasculature and to enhance the efficacy of chemotherapy.
    Darge HF; Andrgie AT; Hanurry EY; Birhan YS; Mekonnen TW; Chou HY; Hsu WH; Lai JY; Lin SY; Tsai HC
    Int J Pharm; 2019 Dec; 572():118799. PubMed ID: 31678386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristic and effective usage of adriamycin].
    Horiuchi K; Akimoto M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
    Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
    Hinotsu S; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T; Obata K; Ohashi Y; Ohe H; Shimazaki J; Tashiro K;
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):73-80. PubMed ID: 11816482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer.
    Yamamoto Y; Nasu Y; Saika T; Akaeda T; Tsushima T; Kumon H
    BJU Int; 2000 Nov; 86(7):802-4. PubMed ID: 11069404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.